JPLA
ZSAN

Joseph P. Lucia & Associates’s Zosano Pharma Corporation ZSAN Stock Holding History

Joseph P. Lucia & Associates’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed – – 631
2020
Q4 		$0 Buy
+10
New +$196 ﹤0.01% 510

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Joseph P. Lucia & Associates's ZSAN Position: Q1 2021 in Review

Joseph P. Lucia & Associates sold out of Zosano Pharma Corporation (ZSAN) in Q1 2021, closing a stake of 10 shares.

Joseph P. Lucia & Associates first reported a position in ZSAN in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 35 funds tracked by Wall St. Rank hold ZSAN as of Q1 2021.

  • Joseph P. Lucia & Associates reported no remaining Zosano Pharma Corporation position as of Q1 2021 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 10 Zosano Pharma Corporation shares in Q1 2021.
  • Joseph P. Lucia & Associates first reported a position in Zosano Pharma Corporation in Q4 2020 and held it in 1 quarter.
  • Joseph P. Lucia & Associates's Zosano Pharma Corporation position peaked at $0 in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2021.

Based on Joseph P. Lucia & Associates's 13F filing for Q1 2021, filed 23 Apr 2021.